معرفی
Lizeth Orozco is an Adjunct Research Fellow at the UWA Medical School, affiliated with The Kids Research Institute Australia (Telethon Kids Institute) and Setonix Pharmaceuticals. Her research focuses on enhancing cancer immunotherapy by targeting novel molecules in combination with standard treatments. She completed her PhD in Biomedical Sciences in 2023.
- Education
- BSc in Biotechnology Engineering, ITESM Campus Guadalajara (2013)
- MSc in Stem Cell Technology, University of Nottingham (2016)
- PhD in Biomedical Sciences, University of Western Australia (2023)
Her research spans cancer immunotherapy, drug target identification, and tumour microenvironment modulation. Recent work analyzes how antimetabolite chemotherapy, TLR agonists, and small molecules like Tretinoin can enhance immune checkpoint blockade efficacy.
- Key article trends
- 2024 studies on LAG-3 expression, TLR agonist synergy, and retinoid-chemotherapy interactions
- 2023 preclinical mesothelioma drug testing
She leads biological research at Setonix Pharmaceuticals and contributes to academic discourse on scientific ethics.
۰مقاله منتشرشده
Lizeth Orozco در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
Catherine RinaldiThe University of Western Australia · پژوهشگر- FFrancois RwandamuriyeThe University of Western Australia · پژوهشگر ارشد
Paul StuppleMonash University · استاد
Jessica BuckThe University of Western Australia · استاد مدعو
Laurence CheungCurtin University · دانشیار- GGabriella AntignaniUniversity of Helsinki · پژوهشگر